TissueGnostics is focused on integrated solutions for the scanning and analysis of microscopy slides, cytospins, smears and tissue microarrays. [ + ]

Researchers have developed a vaccine delivery technology that enables treatment to be tailored for different cancers, improving the precision of cancer immunotherapy. [ + ]

Fresche Bioscience has signed an agreement to support manufacture of Stayzon's range of antimicrobial coatings and ancillary treatments. [ + ]

Global Kinetics Corporation has received funding for its work improving the lives of those with Parkinson's disease using advanced medical technologies. [ + ]

Science & Technology Australia and the American Association for the Advancement of Science have pledged to foster collaborations to enhance the role of STEM on the global stage. [ + ]

AVITA Medical has conducted a pivotal clinical trial demonstrating the effectiveness of its ReCell Autologous Cell Harvesting Device in the treatment of second-degree burns. [ + ]

Kazia Therapeutics' small molecule inhibitor is being developed to treat glioblastoma multiforme — the most common and aggressive form of primary brain cancer. [ + ]

Science and technology company Merck was named the Best Bioprocessing Supplier at the Asia-Pacific Bioprocessing Excellence Awards 2018, held earlier this year. [ + ]

The Hunter Medical Research Institute has launched a web platform that will help unravel the mysteries behind undiagnosed intellectual disabilities in children. [ + ]

A clinical study has indicated the positive effects of Lipogen PMS, a natural phospholipid formulation, in treating and relieving premenstrual syndrome (PMS) symptoms. [ + ]

Experiencing cancer is tough for any patient, as well as their family and friends. But it seems that cancer is also not great for the Australian economy. [ + ]

The NHMRC Clinical Trial Centre will use technology company Medidata's unified platform and analytics for all major new studies starting in 2018. [ + ]

The Garvan Institute of Medical Research has appointed Professor Chris Goodnow as its executive director. [ + ]

Made from tiny nanorods, the newly developed 'NanoZymes' use visible light to create highly reactive oxygen species that rapidly break down and kill bacteria. [ + ]

Researchers now have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain. [ + ]